Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
Citations Report - Journal of Diabetes and Clinical Practice

Journal of Diabetes & Clinical Practice
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Articles published in Journal of Diabetes & Clinical Practice have been cited by esteemed scholars and scientists all around the world. Journal of Diabetes & Clinical Practice has got h-index 4, which means every article in Journal of Diabetes & Clinical Practice has got 4 average citations.

Following are the list of articles that have cited the articles published in Journal of Diabetes & Clinical Practice.

  2023 2022 2021 2020 2019 2018 2017 2016

Year wise published articles

55 31 31 37 12 9 0 0

Year wise citations received

11 24 23 28 16 13 14 20
Journal total citations count 284
Journal impact factor 0.75
Journal 5 years impact factor 0.86
Journal cite score 0.81
Journal h-index 4
Journal h-index since 2018 4
image

Lee, H., Park, S. E., & Kim, E. Y. (2021). Glycemic Variability Impacted by SGLT2 Inhibitors and GLP 1 Agonists in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis. Journal of clinical medicine, 10(18), 4078.

  View at Publisher | View at Google Scholar | View at Indexing
image

Jiang, L. L., Zhang, P., Liu, B. L., Yan, R. N., Ye, L., Ma, J. H., & Li, F. F. (2021). Effects of Dapagliflozin Adjunct to Insulin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized, Controlled, Open-Labeled Trial. BioMed Research International, 2021.

  View at Publisher | View at Google Scholar | View at Indexing
image

Lin, C., Cai, X., Yang, W., Lv, F., Nie, L., & Ji, L. (2020). Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus. BMC medicine, 18(1), 1-23.

  View at Publisher | View at Google Scholar | View at Indexing
image

Ceriello, A., Ofstad, A. P., Zwiener, I., Kaspers, S., George, J., & Nicolucci, A. (2020). Long-Term HbA1c Variability and Cardiovascular Death: Insights from the EMPA-REG OUTCOME Trial.

  View at Publisher | View at Google Scholar | View at Indexing
image

Li, F. F., Liu, B. L., Yin, G. P., Yan, R. N., Zhang, D. F., Wu, J. D., ... & Ma, J. H. (2018). Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes. Scientific reports, 8(1), 1-7.

  View at Publisher | View at Google Scholar | View at Indexing
image

Stelmaszyk, A., Weso?owska, A., Pomieczy?ska, K., Iskakova, S., Frydrychowicz, M., Dworacki, G., & Dworacka, M. (2018). The impact of dapagliflozin on glucose excursions related to early proatherogenic derangement in the aortic wall. Saudi pharmaceutical journal, 26(8), 1192-1198.

  View at Publisher | View at Google Scholar | View at Indexing
image

Unnikrishnan, A. G., Saboo, B., Joshi, S., Kesavadev, J., Makkar, B. M., Agarwal, S., ... & Tiwaskar, M. (2019). Consensus Statement on Use of Ambulatory Glucose Profile in Patients with Type 2 Diabetes Mellitus Receiving Oral Antidiabetic Drugs. The Journal of the Association of Physicians of India, 67(11), 76-83.

  View at Publisher | View at Google Scholar | View at Indexing
image

Milonas, D., & Tziomalos, K. (2018). Sodium-glucose cotransporter 2 inhibitors and ischemic stroke. Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current Drug Targets-Cardiovascular & Hematological Disorders), 18(2), 134-138.

  View at Publisher | View at Google Scholar | View at Indexing
image

Verbovoy, A. F., Pashentseva, A. V., Verbovaya, N. I., Madyanov, I. V., Sharonova, L. A., & Galkin, R. A. (2018). Modern approaches to management of cardiovascular risk factors at patients with diabetes mellitus type 2. Terapevticheskii arkhiv, 90(8), 113-117.

  View at Publisher | View at Google Scholar | View at Indexing
image

Ceriello, A., Ofstad, A. P., Zwiener, I., Kaspers, S., George, J., & Nicolucci, A. (2020). Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial. Cardiovascular diabetology, 19(1), 1-7.

  View at Publisher | View at Google Scholar | View at Indexing
image

Handelsman, Y. (2019). Rationale for the early use of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes. Advances in therapy, 36(10), 2567-2586.

  View at Publisher | View at Google Scholar | View at Indexing
image

Araki, E., Watada, H., Uchigata, Y., Tomonaga, O., Fujii, H., Ohashi, H., ... & Langkilde, A. M. (2020). Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT?5): 52?week results from a randomized, open?label, phase III clinical trial. Diabetes, Obesity and Metabolism, 22(4), 540-548.

  View at Publisher | View at Google Scholar | View at Indexing
image

Papakitsou, I., Vougiouklakis, G., Elisaf, M. S., & Filippatos, T. D. (2019). Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes. Clinical pharmacology: advances and applications, 11, 133.

  View at Publisher | View at Google Scholar | View at Indexing
image

Saleem, F. (2017). Dapagliflozin: cardiovascular safety and benefits in type 2 diabetes mellitus. Cureus, 9(10).

  View at Publisher | View at Google Scholar | View at Indexing
image

Palanisamy, S., Yien, E. L. H., Shi, L. W., Si, L. Y., Qi, S. H., Ling, L. S. C., ... & Chen, Y. N. (2018). Systematic review of efficacy and safety of newer antidiabetic drugs approved from 2013 to 2017 in controlling HbA1c in diabetes patients. Pharmacy, 6(3), 57.

  View at Publisher | View at Google Scholar | View at Indexing
image

Li, F. F., Liu, B. L., Yan, R. N., Zhu, H. H., Zhou, P. H., Li, H. Q., ... & Ma, J. H. (2017). Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA 1c values. Scientific reports, 7(1), 1-7.

  View at Publisher | View at Google Scholar | View at Indexing
image

Chehregosha, H., Khamseh, M. E., Malek, M., Hosseinpanah, F., & Ismail-Beigi, F. (2019). A view beyond HbA1c: role of continuous glucose monitoring. Diabetes Therapy, 10(3), 853-863.

  View at Publisher | View at Google Scholar | View at Indexing
image

Luc, K., Schramm-Luc, A., Guzik, T. J., & Mikolajczyk, T. P. (2019). Oxidative stress and inflammatory markers in prediabetes and diabetes. J. Physiol. Pharmacol, 70(6), 809-824.

  View at Publisher | View at Google Scholar | View at Indexing
image

Rådholm, K., Wu, J. H., Wong, M. G., Foote, C., Fulcher, G., Mahaffey, K. W., ... & Neal, B. (2018). Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes–A systematic review. diabetes research and clinical practice, 140, 118-128.

  View at Publisher | View at Google Scholar | View at Indexing
image

Hayashi, T., Fukui, T., Nakanishi, N., Yamamoto, S., Tomoyasu, M., Osamura, A., ... & Hirano, T. (2017). Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin. Cardiovascular diabetology, 16(1), 1-13.

  View at Publisher | View at Google Scholar | View at Indexing
Peer Reviewed Journals

Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

agriaquaculture@omicsonline.com

+1-702-714-7001Extn: 9040

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

chemistryjournals@omicsonline.com

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

clinicaljournals@omicsonline.com

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engineeringjournals@omicsonline.com

1-702-714-7001Extn: 9042

General Science

Andrea Jason

generalscience@omicsonline.com

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

geneticsmolbio@omicsonline.com

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immunomicrobiol@omicsonline.com

1-702-714-7001Extn: 9014

Nursing & Health Care Journals

Stephanie Skinner

nursinghealthcare@omicsonline.com

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

medicaljournals@omicsonline.com

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuropsychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

pharmajournals@omicsonline.com

1-702-714-7001Extn: 9007

 
© 2008- 2024 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version